VivoSeq
Nephrology

Kidney Stones

0

Pipeline Programs↗

8

Active Trials↗

3

Companies Involved↗

Kidney Stones is an early-stage landscape with 0 programs across 3 companies. The most active players are Allena Pharmaceuticals, Lilac Therapeutics, Inc., Storz Medical AG.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

27/100

Mech. Concentration

N/A

Completion Rate

82/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

A

Allena Pharmaceuticals

0 programs

PreclinicalL

Lilac Therapeutics, Inc.

0 programs

PreclinicalS

Storz Medical AG

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

19

clinical trials

Completed9 · 47%
Recruiting5 · 26%
Not yet recruiting3 · 16%
Withdrawn2 · 11%

Clinical Trials

Trial Activity

19 trials

Impact of Forced Diuresis on the Residual Fragment Rate After Flexible Ureteroscopy for Destruction of Kidney Stones With Laser
Recruiting·UUniversity Hospital, Tours·Phase 3·NCT05916963·374 enrolled
SGLT2i in Kidney Stones
Recruiting·UUniversity of Chicago·Phase 1·NCT07055282·32 enrolled
Modified Mini Percutaneous Nephrolithotomy Versus Standard Percutaneous Nephrolithotomy for the Treatment of Complex Renal Calculi: A Multicenter Randomized Controlled Trial
Recruiting·TThe First Affiliated Hospital of Guangzhou Medical University·Preclinical·NCT07697677·1,380 enrolled
Prospective Single-center Study Comparing Thulium Fiber Laser to Pulsed Thulium:YAG Laser in the Ureteroscopic Treatment of Nephrolithiasis
Recruiting·UUniversity of California, San Diego·Preclinical·NCT06721975·50 enrolled
Post-Market Clinical Follow-Up Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones - A Confirmatory Parallel-Group, Randomized Controlled Trial
Recruiting·SStorz Medical AG·Preclinical·NCT07272720·126 enrolled
Metaphylaxis of Infected Kidney Stones After Percutaneous Nephrolithotripsy
Not yet recruiting·WWest Kazakhstan Marat Ospanov Medical University·N/A·NCT07393711·95 enrolled
Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones
Not yet recruiting·UUniversity of California, Los Angeles·Phase 1/2·NCT07408076·30 enrolled
The Effect of Apple Cider Vinegar Supplementation on 24-hour Urine Chemistry in Adults
Not yet recruiting·UUniversity of Chicago·Preclinical·NCT07389226·30 enrolled
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days
Completed·AAllena Pharmaceuticals·Phase 2·NCT02547805·66 enrolled
Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Hyperoxaluria and Kidney Stones
Completed·AAllena Pharmaceuticals·Phase 2·NCT02503345·32 enrolled
A Phase 2a Study of LLX-424 in Patients With a History of Kidney Stones
Completed·LLilac Therapeutics, Inc.·Phase 2·NCT06932146·51 enrolled
A Clinical Study to Evaluate the Efficacy of Two Siddha Drugs Sindhuvallathy Mezhugu and Kalladaippu Kudineer for Kidney Stones
Completed·TTamil Nadu Dr.M.G.R.Medical University·N/A·NCT01847963·120 enrolled
Use of Lapis Judaicus to Dissolve Kidney Stones
Completed·SShiraz University of Medical Sciences·Phase 1/2·NCT01443702·60 enrolled
Use of an Herbal Preparation to Prevent and Dissolve Kidney Stones
Completed·MMayo Clinic·Phase 1/2·NCT00381849·20 enrolled
A Study to Assess the Effect of Cannabidiol Oil on Pain After Ureteroscopy for Kidney Stones
Completed·MMayo Clinic·Phase 2/3·NCT04387617·90 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)